Amy Feldman

In this week's edition of InnovationRx, we look at the boom in autoimmune disease therapies, OpenAI's healthcare push, Vertex's $10 billion purchase of Crinetics, and more.

In this week's edition of InnovationRx, Thyme Care gets new leadership, the intestinal illness spreads, Chai Discovery confirms its $400 million raise, and more.

With an FDA panel expected to recommend legal production of as many as seven peptides this week, compounding pharmacies and telehealth companies are preparing for the coming bonanza.

In this week's edition of InnovationRx, we look at the havoc of generic drug tariffs, the companies looking to cash in on the coming peptide

In this week's edition of InnovationRx, we look at Fortell's efforts to make a better hearing aid, Abby Care's business getting payment for

E ven before it gets approval for its sleep apnea pill, Apnimed is testing investor appetite.

In this week’s edition of InnovationRx, we look at the potential impact of Trump’s executive order on vaccines, the healthcare dynamos on Forbes 50 Over 50, a Swiss startup focused on a rare bleeding disorder, and more.

In this week's edition of InnovationRx, we look at Summa Health's first tech bets, the healthcare leaders on Forbes Veteran 250 list, BioMarin's acquisition of an early-stage bone disease therapy, and more.

In this week's edition of InnovationRx, we look at Summa Health's first tech bets, the healthcare leaders on Forbes Veteran 250 list, BioMarin's acquisition of an early-stage bone disease therapy, and more.

or more than 100 years, the billionaire Angelini family had been content to run a largely European business empire from their headquarters in